{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362544420347355136.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1017/s1461145709009948"}},{"identifier":{"@type":"URI","@value":"http://academic.oup.com/ijnp/article-pdf/12/7/941/2060875/12-7-941.pdf"}}],"dc:title":[{"@value":"Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382544420347355137","@type":"Researcher","foaf:name":[{"@value":"Mei Han"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420347355136","@type":"Researcher","foaf:name":[{"@value":"Xu-Feng Huang"}]},{"@id":"https://cir.nii.ac.jp/crid/1382544420347355008","@type":"Researcher","foaf:name":[{"@value":"Chao Deng"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"14611457"},{"@type":"EISSN","@value":"14695111"}],"prism:publicationName":[{"@value":"The International Journal of Neuropsychopharmacology"}],"dc:publisher":[{"@value":"Oxford University Press (OUP)"}],"prism:publicationDate":"2009-02-10","prism:volume":"12","prism:number":"07","prism:startingPage":"941"},"reviewed":"false","url":[{"@id":"http://academic.oup.com/ijnp/article-pdf/12/7/941/2060875/12-7-941.pdf"}],"createdAt":"2009-02-10","modifiedAt":"2025-02-07","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004231952599040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Partial regimen replacement with aripiprazole reduces serum prolactin in patients with a long history of schizophrenia: A case series"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1017/s1461145709009948"},{"@type":"CROSSREF","@value":"10.1016/j.ajp.2016.10.005_references_DOI_OaTsr4nMqAn64xGwUedsBWqUvfh"}]}